Takako Eguchi Nakajima
Overview
Explore the profile of Takako Eguchi Nakajima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
1741
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakajima T
Gan To Kagaku Ryoho
. 2024 Dec;
51(12):1181-1185.
PMID: 39721773
There exist many issues concerning human resources development in cancer research. Not a single solution does not work, but correlative issues should be continuously and comprehensively considered. Board certification platform,...
2.
3.
Murakami M, Miyata Y, Nakashima K, Abe M, Nishimura J, Wada M, et al.
Int J Clin Oncol
. 2024 Nov;
30(1):27-39.
PMID: 39570460
Background: Olanzapine is an atypical antipsychotic drug used for chemotherapy-induced nausea and vomiting. It is particularly effective in preventing delayed nausea and vomiting induced by highly emetogenic chemotherapy (HEC). However,...
4.
Nakashima K, Harashima S, Kaneko R, Tanaka R, Abe M, Wada M, et al.
Int J Clin Oncol
. 2024 Nov;
30(1):17-26.
PMID: 39531096
Background: A standardized multi-day antiemetic regimen for multi-day chemotherapy remains elusive. This systematic review evaluated the efficacy and safety of multi-day antiemetic regimens in patients undergoing multi-day intravenous chemotherapy. Methods:...
5.
Morizane C, Ueno M, Ioka T, Tajika M, Ikeda M, Yamaguchi K, et al.
Cancer Sci
. 2024 Oct;
116(1):192-203.
PMID: 39462221
Fibroblast growth factor receptors (FGFRs) are a highly conserved family of transmembrane receptor tyrosine kinases with multiple roles in the regulation of key cellular processes. Specific FGFR mutations have been...
6.
Nakashima K, Yokomizo A, Murakami M, Okita K, Wada M, Iino K, et al.
Int J Clin Oncol
. 2024 Oct;
29(12):1785-1794.
PMID: 39417943
Background: Palonosetron, a second-generation 5-HT receptor antagonist (5-HTRA), is more effective than first-generation 5-HTRA. Several studies have investigated whether dexamethasone (DEX), when combined with palonosetron as a 5-HTRA, can be...
7.
Yokomizo A, Nakashima K, Iba A, Okita K, Wada M, Iino K, et al.
Int J Clin Oncol
. 2024 Sep;
29(11):1632-1640.
PMID: 39340704
Background: Chemotherapy-induced nausea and vomiting (CINV) are common side effects, classified according to timing and severity. Conventional agents such as dexamethasone are effective but have various side effects. For moderately...
8.
Hayashi T, Yamamoto S, Miyata Y, Takeda M, Abe M, Wada M, et al.
Int J Clin Oncol
. 2024 Sep;
29(11):1616-1631.
PMID: 39259324
Background: Chemotherapy-induced nausea and vomiting (CINV) commonly affects patient quality of life and the overall effectiveness of chemotherapy. This study aimed to evaluate whether adding neurokinin-1 receptor antagonists (NK1RAs) to...
9.
Ono M, Takai Y, Harada M, Horie A, Dai Y, Kikuchi E, et al.
Int J Clin Oncol
. 2024 Sep;
29(12):1959-1966.
PMID: 39231915
Background: The expenses related to fertility preservation or subsequent assisted reproductive treatments are significant for adolescents and young adult patients in Japan's current healthcare system. With fertility preservation becoming more...
10.
Katada C, Yokoyama T, Watanabe A, Hara H, Yoshii T, Fujii H, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jul;
120(5):1353-1362.
PMID: 38969179
Purpose: This study aimed to assess the viability of definitive chemoradiotherapy (dCRT) as an organ-preservation strategy for remarkable responders who were downstaged to stage IA after receiving induction chemotherapy for...